Four‐factor prothrombin complex concentrate reverses apixaban‐associated bleeding in a rabbit model of acute hemorrhage

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|12|2220-2226

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.12, 2015-12, pp. : 2220-2226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased risk of volume overload with plasma compared with four‐factor prothrombin complex concentrate for urgent vitamin K antagonist reversal

By  

TRANSFUSION, Vol. 55, Iss. 11, 2015-11 ,pp. : 2722-2729

John Wiley & Sons Inc

Access to resources Recommend Favorite

Air Ambulance Delivery and Administration of Four‐factor Prothrombin Complex Concentrate Is Feasible and Decreases Time to Anticoagulation Reversal

By  

ACADEMIC EMERGENCY MEDICINE, Vol. 25, Iss. 1, 2018-01 ,pp. : 33-40

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of prothrombin complex concentrate administration and hematoma enlargement in non–vitamin K antagonist oral anticoagulant–related intracerebral hemorrhage

By  

ANNALS OF NEUROLOGY, Vol. 83, Iss. 1, 2018-01 ,pp. : 186-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prothrombin complex concentrate for factor VII replacement in a patient undergoing left ventricular assist device implantation with factor VII deficiency

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : E185-E185

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on‐demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in Spain

By  

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 320-329

John Wiley & Sons Inc

Access to resources Recommend Favorite